[1]孙林芳 朱凌燕.老年心房颤动患者抗凝服药依从性及其影响因素分析[J].心血管病学进展,2020,(9):978-983.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.022]
　SUN Linfang,ZHU Lingyan.Compliance with Anticoagulant Medication and Its Influencing Factors in Elderly Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(9):978-983.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.022]
点击复制

老年心房颤动患者抗凝服药依从性及其影响因素分析()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年9期
页码:
978-983
栏目:
出版日期:
2020-09-25

文章信息/Info

Title:
Compliance with Anticoagulant Medication and Its Influencing Factors in Elderly Patients with Atrial Fibrillation
作者:
孙林芳1; 2 朱凌燕1; 3
(1．上海交通大学护理学院,上海 200025 ；2. 上海交通大学附属第六人民医院老年科,上海 200233；3. 上海交通大学附属第六人民医院护理部,上海 200233)
Author(s):
SUN Linfang1; 2; ZHU Lingyan1; 3
(1.School of NursingShanghai Jiaotong UniversityShanghai 200025China；2.Department of GeriatricsThe Sixth Peoples Hospital Affiliated to Shanghai Jiaotong UniversityShanghai 200233China；3.Department of NursingThe Sixth Peoples Hospital Affiliated to Shanghai Jiaotong UniversityShanghai 200233China)
关键词:
老年人; 心房颤动; 抗凝; 服药依从性
Keywords:
Elderly patients Atrial fibrillation Anticoagulant Medication compliance
DOI:
10.16806/j.cnki.issn.1004-3934.2020.09.022
摘要:
目的 探讨老年心房颤动患者抗凝服药依从性的影响因素。方法 采用便利抽样法，运用自制一般资料问卷和中文修订版中文含义？（MMAS-8）量表慢性病自我效能量表，于2019年3—8月对上海市第六人民医院心血管内科的118例老年心房颤动抗凝患者进行调查。结果 老年心房颤动患者抗凝服药高度依从为35例（33.3%）；出院后2周自我效能得分（7.51±1.72）分；抗凝服药依从性与自我效能呈正相关（r＝0.505，P＜0.01）；文化程度、收入水平、是否医保患者和既往住院次数是抗凝服药依从性的主要影响因素，差异具有统计学意义（P＜0.05）。结论 老年心房颤动患者抗凝服药依从性较差，自我效能越高其依从性越好，需高度重视低文化水平、低收入、非医保和既往入院次数较少的患者。
Abstract:
Objective To explore the influencing factors for compliance with anticoagulant medication in elderly patients with atrial fibrillation. Methods 118 elderly anticoagulant patients with atrial fibrillation in Cardiology Department of Shanghai Sixth Peoples Hospital from March to August in 2019 were enrolled and investigated by convenience sampling method, self-made general data questionnaire and Chinese revised MMAS-8 Chronic Disease Self-Efficacy Scale. Results Within the elderly patients with atrial fibrillation, 35 cases(33.3%) manifested as high compliance with anticoagulant therapy. The self-efficacy score after discharge for 2 weeks was 7.51±1.72. The compliance with anticoagulant medication was positively correlated with self-efficacy(r＝0.505, P0.01). The educational level, income level, medical insurance and frequency of previous hospitalizations were the main influencing factors for compliance with anticoagulant medication, and the differences were statistically significant(P＜0.05). Conclusion The elderly patients with atrial fibrillation have poor compliance with anticoagulant medication, which will be increased with the elevation of self-efficacy. The patients with low education and income level, non-medical insurance and fewer hospitalizations need special attention.

参考文献/References:

[1] Wang X, Fu Q, Song F,et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke:results from a national stroke screening survey[J]. Int J Cardiol,2018,271:92-97.
[2] Chugh SS,Havmoeller R,Narayanan K,et al. Worldwide epidemiology of atrial fibrillation:a Global Burden of Disease 2010 Study[J]. Circulation,2014,129(8):837-847.
[3] 张维,刘千军,韩维嘉等. 社区老年人群心房颤动的现况研究[J].中华老年心脑血管病杂志,18(6):608-611.
[4] 闫静静. 亚洲心房颤动抗凝现状及与非亚洲抗凝策略的比较[J]. 心血管病学进展,2018,39(6):884-888.

相似文献/References:

[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
　HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(9):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
　DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(9):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
　ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
　ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
　HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
　WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
　XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
　ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(9):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
　WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(9):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
　ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(9):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]

备注/Memo

备注/Memo:
收稿日期：2020-01-05 基金项目：上海交通大学附属第六人民医院院级课题（yjhl-2017-10-2045） 通信作者：朱凌燕，E-mail:juliets@aliyun.com
更新日期/Last Update: 2020-12-03